SIGA Technologies Inc
NASDAQ:SIGA
SIGA Technologies Inc
Pre-Tax Income
SIGA Technologies Inc
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SIGA Technologies Inc
NASDAQ:SIGA
|
Pre-Tax Income
$76.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Pre-Tax Income
$26.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Pre-Tax Income
-$8.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Pre-Tax Income
$8B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Pre-Tax Income
$19.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
23%
|
CAGR 10-Years
1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Pre-Tax Income
$12.7B
|
CAGR 3-Years
27%
|
CAGR 5-Years
19%
|
CAGR 10-Years
16%
|
|
SIGA Technologies Inc
Glance View
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company is headquartered in New York City, New York and currently employs 39 full-time employees. The Company’s lead product, TPOXX (oral TPOXX), is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The firm does not have a manufacturing infrastructure and does not intend to develop one for the manufacture of TPOXX. The company uses contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company’s CMOs apply methods and controls in facilities, which are uses for manufacturing, processing, packaging, testing, analyzing and holding pharmaceuticals, which conform to current good manufacturing practices (cGMP), the standard set by the FDA for manufacture and storage of pharmaceuticals intended for human use. For the manufacture of oral TPOXX, the Company uses the four CMOs, namely W.R. Grace and Company; Powdersize, LLC; Catalent Pharma Solutions LLC, and Packaging Coordinators, LLC.
See Also
What is SIGA Technologies Inc's Pre-Tax Income?
Pre-Tax Income
76.1m
USD
Based on the financial report for Dec 31, 2024, SIGA Technologies Inc's Pre-Tax Income amounts to 76.1m USD.
What is SIGA Technologies Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
-5%
Over the last year, the Pre-Tax Income growth was -13%. The average annual Pre-Tax Income growth rates for SIGA Technologies Inc have been -5% over the past three years .
You don't have any saved screeners yet